My Account Follow us on: Powered By  See the top gainers, losers, invest and get updated what's happening in the crypto market Invest Now Powered By  India's Largest Regional Retail Option Traders Summit. (BOTS) is a prestigious options trading event organized by Traders Gurukul. Held on the 2nd OR 3rd Sunday of every month, across top cities in India Invest Now Powered By  This functionality will provide users with ease of access navigation and enable create a new revenue line by generating leads of potential customers for brokers in a more integrated manner. Invest Now Medicamen Biotech shares were up 6 percent at Rs 759.20 on July 19 at 1:15 pm, with 56,517 shares changing hands on NSE. Medicamen has successfully filed its first Abbreviated New Drug Application (ANDA) for the BORTEZOMIB injection with the US Food and Drug Administration (USFDA), the company announced on July 19 through a filing to the exchanges. Also Read: Hold Polycab India; target of Rs 4100: ICICI Securities “This is major milestone for the Company which will trigger USFDA Audit in due course of time” said Medicamen. For the quarter ended March, the company reported a 20 percent year-on-year increase in revenue to Rs 138 crore in FY23 as against the previous year. The Operating Profit Margins fell to 18 percent while the net profit retained the Rs 15 crore value. The Earnings per Share (EPS) for the stock fell by 3 percent to Rs 11.86 for FY23. The stock has delivered a 11.26 percent return over the past one month and a negative 8.66 percent return over the past six months.
         Top TrendsAngel TaxWiproBudget newsNew Income tax slabIPO News   Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form 
        or medium without express writtern permission of moneycontrol.com is prohibited. You are already a Moneycontrol Pro user.